Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 1/20 | 0.60 |
| ▸ | HSD17B3 | P37058 | 7/20 | 0.59 |
| ▸ | HTT | P42858 | 2/20 | 0.59 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.50 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.50 |
| ▸ | PLA2G5 | P39877 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | STS | P08842 | 4/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | KAT8 | Q9H7Z6 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21839460 | 0.98 | HTT (0.60) | PPARAHSD17B3HTTFFAR1PLA2G2A | |
| SCHEMBL222170 | 0.88 | KAT8 (0.60) | PPARAHSD17B3HTTFFAR1PLA2G2A | |
| SCHEMBL10595067 | 0.88 | KAT8 (0.60) | PPARAHSD17B3HTTFFAR1PLA2G2A | |
| SCHEMBL29406518 | 0.88 | KAT8 (0.60) | PPARAHSD17B3HTTFFAR1PLA2G2A | |
| SCHEMBL1576935 | 0.88 | KAT8 (0.60) | PPARAHSD17B3HTTFFAR1PLA2G2A | |
| SCHEMBL82454 | 0.88 | KAT8 (0.60) | PPARAHSD17B3HTTFFAR1PLA2G2A | |
| SCHEMBL220528 | 0.88 | KAT8 (0.60) | PPARAHSD17B3HTTFFAR1PLA2G2A | |
| SCHEMBL10594259 | 0.88 | KAT8 (0.60) | PPARAHSD17B3HTTFFAR1PLA2G2A | |
| SCHEMBL31751243 | 0.88 | KAT8 (0.60) | PPARAHSD17B3HTTFFAR1PLA2G2A | |
| SCHEMBL29623899 | 0.88 | KAT8 (0.60) | PPARAHSD17B3HTTFFAR1PLA2G2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8609117-B2 | Compositions comprising jasmonic acid derivatives and use of the derivatives | L'OREAL S.A. (FR) | 2013-12-17 | — | — | US | disclosed |
| US-8603502-B2 | Compositions comprising jasmonic acid derivatives and use of these derivatives | L'OREAL S.A. (FR) | 2013-12-10 | — | — | US | disclosed |
| US-8481594-B2 | Compositions comprising jasmonic acid derivatives and use of these derivatives | L'OREAL S. A. (FR) | 2013-07-09 | — | — | US | disclosed |
| US-20120282197-A1 | USE OF PIPERIDINE ESTER DERIVATIVE AS SOLVENT IN COSMETIC COMPOSITIONS; COSMETIC COMPOSITIONS COMPRISING IT | L'OREAL (FR) | 2012-11-08 | — | — | US | disclosed |
| US-20120282197-A1 | USE OF PIPERIDINE ESTER DERIVATIVE AS SOLVENT IN COSMETIC COMPOSITIONS; COSMETIC COMPOSITIONS COMPRISING IT | L'OREAL (FR) | 2012-11-08 | — | — | US | disclosed |
| US-20120269746-A1 | USE OF CAPROLACTAM DERIVATIVE AS SOLVENT IN COSMETIC COMPOSITIONS; COSMETIC COMPOSITIONS COMPRISING IT | L'OREAL (FR) | 2012-10-25 | — | — | US | disclosed |
| US-20120269746-A1 | USE OF CAPROLACTAM DERIVATIVE AS SOLVENT IN COSMETIC COMPOSITIONS; COSMETIC COMPOSITIONS COMPRISING IT | L'OREAL (FR) | 2012-10-25 | — | — | US | disclosed |
| WO-2011038778-A1 | USE OF CAPROLACTAM DERIVATIVE AS SOLVENT IN COSMETIC COMPOSITIONS; COSMETIC COMPOSITIONS COMPRISING IT | L'OREAL (FR) | 2011-04-07 | — | — | WO | disclosed |
| WO-2011038776-A1 | USE OF PIPERIDINE ESTER DERIVATIVE AS SOLVENT IN COSMETIC COMPOSITIONS; COSMETIC COMPOSITIONS COMPRISING IT | L'OREAL (FR) | 2011-04-07 | — | — | WO | disclosed |
| US-20100179222-A1 | COMPOSITIONS COMPRISING JASMONIC ACID DERIVATIVES AND USE OF THESE DERIVATIVES | L'OREAL S.A. | 2010-07-15 | — | — | US | disclosed |
| US-20100143276-A1 | Ester solvents derived from 4-carboxy-2-pyrrolidinone formulated into UV-screening cosmetic compositions | L'OREAL (FR) | 2010-06-10 | — | — | US | disclosed |
| US-20100143276-A1 | Ester solvents derived from 4-carboxy-2-pyrrolidinone formulated into UV-screening cosmetic compositions | L'OREAL (FR) | 2010-06-10 | — | — | US | disclosed |
| EP-2193783-A1 | Use of an ester derived from 4-carboxy-2-pyrrolidinone as a solvent in cosmetic compositions; cosmetic compositions containing same | L'Oreal (FR) | 2010-06-09 | — | — | EP | disclosed |
| US-20100069497-A1 | COMPOSITIONS COMPRISING JASMONIC ACID DERIVATIVES AND USE OF THESE DERIVATIVES | L'OREAL | 2010-03-18 | — | — | US | disclosed |
| US-20040029839-A1 | Compositions comprising jasmonic acid derivatives and use of these derivatives | L'OREAL S.A. (FR) | 2004-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100069497-A1 | COMPOSITIONS COMPRISING JASMONIC ACID DERIVATIVES AND USE OF THESE DERIVATIVES | CBR1, CBR3, DECR1 | PPARA 279/4885HSD17B3 260/4885HTT 3268/4885 |
| US-20040029839-A1 | Compositions comprising jasmonic acid derivatives and use of these derivatives | CBR1, CBR3, DECR1 | PPARA 343/4885HSD17B3 160/4885HTT 2239/4885 |
| US-20100179222-A1 | COMPOSITIONS COMPRISING JASMONIC ACID DERIVATIVES AND USE OF THESE DERIVATIVES | CBR1, CBR3, DECR1 | PPARA 242/4885HSD17B3 251/4885HTT 3246/4885 |
| US-20120282197-A1 | USE OF PIPERIDINE ESTER DERIVATIVE AS SOLVENT IN COSMETIC COMPOSITIONS; COSMETIC COMPOSITIONS COMPRISING IT | PLD1, PLD2, FFAR1 | PPARA 157/4885HSD17B3 517/4885HTT 3363/4885 |
| US-20120269746-A1 | USE OF CAPROLACTAM DERIVATIVE AS SOLVENT IN COSMETIC COMPOSITIONS; COSMETIC COMPOSITIONS COMPRISING IT | DEGS1, CAPN1, PPT1 | PPARA 691/4885HSD17B3 570/4885HTT 3226/4885 |
| US-20100143276-A1 | Ester solvents derived from 4-carboxy-2-pyrrolidinone formulated into UV-screening cosmetic compositions | FASN, ALOX12, PAH | PPARA 70/4885HSD17B3 624/4885HTT 3261/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.